Skip to main content

Closed

BEAM: Beam Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

44thpctl

Volume

0.47×avg

Market Cap

2.63BUSD

P/E Ratio

-41.4TTM

Div Yield

-ann

Beam Therapeutics Inc.

BEAMNASDAQ Global Select·USD·Closed

Beam Therapeutics Inc.

BEAMNASDAQ·USD·Closed

$25.52

−3.66%

$25.52

−$0.97 (3.66%)

52W Range

44thpctl

Volume

0.47×avg

Mkt Cap

2.63BUSD

P/E

-41.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings